EE04819B1 - Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk - Google Patents

Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk

Info

Publication number
EE04819B1
EE04819B1 EEP199900272A EEP9900272A EE04819B1 EE 04819 B1 EE04819 B1 EE 04819B1 EE P199900272 A EEP199900272 A EE P199900272A EE P9900272 A EEP9900272 A EE P9900272A EE 04819 B1 EE04819 B1 EE 04819B1
Authority
EE
Estonia
Prior art keywords
host cell
expression vector
recombinant dna
dna molecule
cell containing
Prior art date
Application number
EEP199900272A
Other languages
English (en)
Estonian (et)
Inventor
Revel Michel
Abramovitch Carolina
Chebath Judith
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900272A publication Critical patent/EE9900272A/xx
Publication of EE04819B1 publication Critical patent/EE04819B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900272A 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk EE04819B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3563697P 1997-01-15 1997-01-15
PCT/US1998/000671 WO1998031796A1 (en) 1997-01-15 1998-01-15 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (2)

Publication Number Publication Date
EE9900272A EE9900272A (et) 2000-02-15
EE04819B1 true EE04819B1 (et) 2007-04-16

Family

ID=21883894

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900272A EE04819B1 (et) 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk

Country Status (20)

Country Link
US (1) US7264945B2 (de)
EP (1) EP1019500B1 (de)
JP (1) JP4614473B2 (de)
KR (2) KR100591988B1 (de)
CN (1) CN1212398C (de)
AT (1) ATE342972T1 (de)
AU (1) AU731206C (de)
BG (1) BG64829B1 (de)
BR (1) BR9806755A (de)
CA (1) CA2276111A1 (de)
CZ (1) CZ299096B6 (de)
DE (1) DE69836226T2 (de)
DK (1) DK1019500T3 (de)
EA (1) EA003250B1 (de)
EE (1) EE04819B1 (de)
ES (1) ES2275297T3 (de)
IL (2) IL130960A0 (de)
NO (1) NO326104B1 (de)
UA (1) UA75560C2 (de)
WO (1) WO1998031796A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119129A1 (en) * 1997-01-15 2002-08-29 Yeda Research And Development Co. Ltd. Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
CA2471385A1 (en) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Preventives/remedies for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220759A1 (de) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
NO326104B1 (no) 2008-09-22
WO1998031796A1 (en) 1998-07-23
ATE342972T1 (de) 2006-11-15
CZ247199A3 (cs) 2000-01-12
AU731206B2 (en) 2001-03-29
IL130960A0 (en) 2001-01-28
EP1019500A4 (de) 2004-04-07
CZ299096B6 (cs) 2008-04-23
BG103627A (en) 2000-04-28
EP1019500B1 (de) 2006-10-18
US20030176678A1 (en) 2003-09-18
DE69836226D1 (de) 2006-11-30
AU731206C (en) 2002-05-16
DK1019500T3 (da) 2007-02-19
NO993412L (no) 1999-07-09
UA75560C2 (en) 2006-05-15
KR20050046779A (ko) 2005-05-18
IL130960A (en) 2008-03-20
EA199900663A1 (ru) 2000-02-28
ES2275297T3 (es) 2007-06-01
JP4614473B2 (ja) 2011-01-19
NO993412D0 (no) 1999-07-09
BG64829B1 (bg) 2006-05-31
KR100799828B1 (ko) 2008-01-31
BR9806755A (pt) 2000-03-14
CN1212398C (zh) 2005-07-27
KR20000070181A (ko) 2000-11-25
DE69836226T2 (de) 2007-02-01
CN1243544A (zh) 2000-02-02
CA2276111A1 (en) 1998-07-23
JP2001508306A (ja) 2001-06-26
KR100591988B1 (ko) 2006-06-21
EA003250B1 (ru) 2003-02-27
EP1019500A2 (de) 2000-07-19
US7264945B2 (en) 2007-09-04
WO1998031796A8 (en) 1999-05-20
AU5824098A (en) 1998-08-07
EE9900272A (et) 2000-02-15

Similar Documents

Publication Publication Date Title
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
DE69433240D1 (de) Apoptosegen von wirbeltieren, zusammensetzungen und verwendungen
DK0669929T3 (da) Elk-ligand, et cytokin
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
BR9507657A (pt) Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
NO20000934L (no) Adipocyttspesifikke proteinhomologer
CY1108459T1 (el) Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων
ATE327328T1 (de) Adipozyten-spezifische protein homologe
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
ATE122394T1 (de) Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.
DK193187D0 (da) Interferoninduceret humanprotein paa ren form, dets fremstilling og anvendlese
IL130960A0 (en) Novel ifn receptor 1 binding proteins dna encoding them and methods of modulating cellular response to interferons
FI950516A0 (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
HUP0001057A2 (hu) A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
WO2001032696A3 (en) Traf family proteins
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.
BR9810046A (pt) Sequência de nucleotìdeos, vetor de expressão, célula hospedeira, proteìna de esperma de mamìfero, proteìna de esperma recombinante, proteìna 4, 1 e/ou 6,7 de esperma, composição farmacêutica, e, vacina contraceptiva

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231